By Kyle Morris

Kerry Group PLC said Tuesday that it has reached agreement to acquire around 92% of c-LEcta GmbH for 137 million euros ($154.9 million), and that it acquired Enmex SA de CV on Dec. 14 for EUR62 million.

The Ireland-based food company said the deal for c-LEcta, a biotechnology innovation company, is strategically important and will accelerate Kerry's innovation capabilities in enzyme engineering, fermentation and bio-process development.

Enmex is a enzyme manufacturer based in Mexico, supplying multiple bio-process solutions for food, beverage and animal-nutrition markets, Kerry said. Enmex's enzyme portfolio and manufacturing infrastructure will extend Kerry's fermentation and enzyme manufacturing capabilities into Latin America, it said.

Write to Kyle Morris at kyle.morris@dowjones.com

(END) Dow Jones Newswires

February 15, 2022 02:57 ET (07:57 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Kerry (PK) (USOTC:KRYAY)
Historical Stock Chart
From Feb 2025 to Mar 2025 Click Here for more Kerry (PK) Charts.
Kerry (PK) (USOTC:KRYAY)
Historical Stock Chart
From Mar 2024 to Mar 2025 Click Here for more Kerry (PK) Charts.